Scientists have found that the protein histone H1.2 and the enzyme PARP1 could be potential therapeutic targets to decrease neurodegeneration in amyotrophic lateral sclerosis (ALS). Amyotrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results